SCHEMBL22552743

SCHEMBL22552743

CC(C)CCCCCC[C@@H](O)[C@@H](C)C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
BLM P54132 1/20 0.45
TRPV1 Q8NER1 1/20 0.43
TRPA1 O75762 1/20 0.43
GPR84 Q9NQS5 4/20 0.42
FFAR1 O14842 1/20 0.42
KDM4C Q9H3R0 2/20 0.41
KDM4A O75164 1/20 0.41
PHF8 Q9UPP1 1/20 0.41
KDM2A Q9Y2K7 1/20 0.41
ABCB1 P08183 1/20 0.39
ACE2 Q9BYF1 1/20 0.38
SPHK1 Q9NYA1 1/20 0.38
LMNA P02545 1/20 0.37
MAPT P10636 1/20 0.36
LCK P06239 1/20 0.36
PPARD Q03181 1/20 0.36
ZDHHC20 Q5W0Z9 1/20 0.36
ZDHHC2 Q9UIJ5 1/20 0.36
TP53 P04637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22552745 1.00 BLM (0.45) BLMTRPV1TRPA1GPR84FFAR1
SCHEMBL1359074 1.00 BLM (0.45) BLMTRPV1TRPA1GPR84FFAR1
SCHEMBL1358682 1.00 BLM (0.45) BLMTRPV1TRPA1GPR84FFAR1
SCHEMBL1359573 1.00 BLM (0.45) BLMTRPV1TRPA1GPR84FFAR1
SCHEMBL1358522 1.00 BLM (0.45) BLMTRPV1TRPA1GPR84FFAR1
SCHEMBL7822400 0.85 GPR84 (0.61) GPR84FFAR1ABCB1ACE2SPHK1
SCHEMBL22552585 0.85 GPR84 (0.61) GPR84FFAR1ABCB1ACE2SPHK1
SCHEMBL7083484 0.85 GPR84 (0.61) GPR84FFAR1ABCB1ACE2SPHK1
SCHEMBL1271078 0.85 GPR84 (0.61) GPR84FFAR1ABCB1ACE2SPHK1
SCHEMBL7080515 0.85 GPR84 (0.61) GPR84FFAR1ABCB1ACE2SPHK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3681875-B1 CYCLIC PEPTIDE ANTIBIOTICS HOFFMANN LA ROCHE (CH) 2026-01-14 EP disclosed
CN-111148739-B Cyclic peptide antibiotics 豪夫迈·罗氏有限公司 2025-06-03 CN disclosed
US-11279735-B2 Cyclic peptide antibiotics GENENTECH, INC. (US) 2022-03-22 US disclosed
US-20200331968-A1 CYCLIC PEPTIDE ANTIBIOTICS GENENTECH, INC. (US) 2020-10-22 US disclosed
CN-111148739-A Cyclopeptide antibiotics 豪夫迈·罗氏有限公司 2020-05-12 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200331968-A1 CYCLIC PEPTIDE ANTIBIOTICS NPPA, LNPEP, CLPP BLM 1490/4885TRPV1 1399/4885TRPA1 1854/4885
US-11279735-B2 Cyclic peptide antibiotics NPPA, LNPEP, CLPP BLM 1490/4885TRPV1 1399/4885TRPA1 1854/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.